INIS
antibodies
100%
arthritis
100%
prediction
100%
peptides
100%
levels
50%
patients
50%
comparative evaluations
50%
receptors
33%
tyrosine
33%
proteins
33%
phosphatases
33%
antigens
16%
increasing
16%
humans
16%
information
16%
damage
16%
space
16%
erosion
16%
bones
16%
adjustments
16%
capacity
16%
x radiation
16%
cartilage
16%
radiographs
16%
Keyphrases
Rheumatoid Arthritis
100%
Radiographic Progression
100%
Anti-mutated Citrullinated Vimentin
100%
Anti-cyclic Citrullinated Peptide Antibody (anti-CCP)
62%
Confidence Interval
25%
Protein Tyrosine Phosphatase Nonreceptor 22
25%
Anti-MCV
25%
Shared Epitope
25%
Joint Damage
12%
Prognostic Information
12%
Human Leukocyte antigen-DRB1
12%
Antibody Status
12%
Anti-citrullinated Protein Antibodies
12%
Radiograph
12%
Total Sharp Score
12%
Joint Space Narrowing
12%
Mere Presence
12%
Cartilage Destruction
12%
Modified Total Sharp Score
12%
Prognostic Capacity
12%
Medicine and Dentistry
Prospective Study
100%
Rheumatoid Arthritis
100%
Vimentin
100%
Inflammatory Arthritis
100%
Mean Corpuscular Volume
37%
Epitope
25%
Non Receptor Protein Tyrosine Phosphatase 22
25%
Human Leukocyte Antigen
12%
Anti-Citrullinated Protein Antibody
12%
Cartilage Degeneration
12%
Peptide Antibody
12%
Pharmacology, Toxicology and Pharmaceutical Science
Prospective Study
100%
Rheumatoid Arthritis
100%
Vimentin
100%
Inflammatory Arthritis
100%
Epitope
25%
Non Receptor Protein Tyrosine Phosphatase 22
25%
Leukocyte Antigen
12%
Cartilage Degeneration
12%
Peptide Antibody
12%
Cyclic Citrullinated Peptide Antibody
12%
Immunology and Microbiology
Inflammatory Arthritis
100%
Peptides
100%
Mean Corpuscular Volume
75%
Epitope
50%
Tyrosine
50%
Cartilage
25%
Human Leukocyte Antigen
25%
Anti-Citrullinated Protein Antibody
25%
Peptide Antibody
25%
Biochemistry, Genetics and Molecular Biology
Vimentin
100%
Prospective Study
100%
Mean Corpuscular Volume
37%
Protein Tyrosine Phosphatase
25%
Human Leukocyte Antigen
12%
Anti-Citrullinated Protein Antibody
12%
Veterinary Science and Veterinary Medicine
Mean Corpuscular Volume
37%
Joint Space
12%